Mateusz Roszak

Mr. Mateusz Roszak

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in Journal of NeuroVirology
Verified
Journal Article
Open access
PDF file
Jakub SadowskiJakub Sadowski
Jakub Sadowski
JHJoanna Huk
Joanna Huk
SOSylwia Otulak
Sylwia Otulak
JZJesica Zawiło
Jesica Zawiło
TKTomasz Klaudel
Tomasz Klaudel
RBRafał Bułdak
Rafał Bułdak
During the COVID-19 pandemic, a statistically significant increase in the incidence of Guillain-Barré syndrome (GBS) has begun to be observed. This article discusses the impact of immunological processes on structural and functional changes in the peripheral nervous system on the pathogenesis of GBS. The aim of the systematic review is to analyze and discuss available information from the scientific literature regarding a possible clinical relationship between SARS-CoV-2 infection along with vaccination mainly, adenovector and mRNA vaccines and the development of different types of Guillain-Barré syndrome. The review specifically discusses the role of proinflammatory cytokines and “cytokine storm” in patients with COVID-19 and their potential impact on the phenomenon of “molecular mimicry” and the generation of autoantibodies in GBS. This issue has been expanded to include information from studies on the impact of vaccination against SARS-CoV-2 virus and the higher number of observed cases of Guillain-Barré syndrome. Focusing on the characteristics of the methods, materials, results and conclusions, the review finally included 114 publications, like studies, meta-analyses, clinical cases and reviews. The systematic review was conducted using PubMed, Google Scholar, and Elsevier databases. It pointed out the molecular and clinical association between SARS-CoV-2 virus infections and COVID-19 vaccination, in the development of Guillain-Barré syndrome in the context of its clinical course.

1 January 2024 in Behavioural Neurology
Verified
Journal Article
Open access
PDF file
DŁDaria Łaskawiec-Żuławińska
Daria Łaskawiec-Żuławińska
Mateusz GrajekMateusz Grajek
Mateusz Grajek
Karolina Helena Krupa-KotaraKarolina Helena Krupa-Kotara
Karolina Helena Krupa-Kotara
PSPatryk Szlacheta
Patryk Szlacheta
HKHasan Karacan
Hasan Karacan
MGMateusz Grajek
Mateusz Grajek
Background. The phenomenon of burnout among healthcare workers during the COVID‐19 pandemic is a widespread problem with several negative consequences for the healthcare system. The many stressors of the pandemic have led to an increased development of anxiety and depressive disorders in many healthcare workers. In addition, some manifested symptoms of the so‐called postpandemic stress syndrome and the emergence of occupational burnout syndrome, commonly referred to as “COVID‐19 burnout.” The aim of this study was to assess the burnout and life satisfaction of healthcare workers during the COVID‐19 pandemic. Materials and Methods. The study was conducted in 2020‐2022 among medical staff working in hospitals in Silesia, Poland. The instruments used to assess life satisfaction and burnout were the Satisfaction with Life Scale (SWLS) and the Maslach Burnout Inventory (MBI), which assesses three dimensions: emotional exhaustion (EE), depersonalisation (DEP), and sense of reduced professional accomplishment (SRPA). Results. The study group included 900 participants. There were 300 physicians (mean age 38 ± 7 years), 300 nurses (mean age 35 ± 6 years), and 300 paramedics (mean age 31 ± 5 years). Life satisfaction as measured by the SWLS was lowest among nurses and paramedics in 2021 and among doctors in 2022. Male respondents and those with fewer years of work had higher levels of life satisfaction. People with more years of work had higher scores in EE and DEP and lower scores in SRPA (p = 0.001). We found a negative correlation between life satisfaction and EE (p = 0.001), DEP (p = 0.001), and SRPA (p = 0.002). Conclusions. The results highlight the need for further research into the causes of burnout among medical professionals and the need for effective interventions to promote well‐being and prevent burnout in this group.

1 January 2025 in Behavioural Neurology
Verified
Journal Article
Open access
ASAlicja Sierakowska
Alicja Sierakowska
ENEwa Niewiadomska
Ewa Niewiadomska
SŁSebastian Łabuda
Sebastian Łabuda
ABAnna Bieniasiewicz
Anna Bieniasiewicz
MRMateusz Roszak
Mateusz Roszak
BŁBeata Łabuz-Roszak
Beata Łabuz-Roszak
Schizophrenia (SZ) is categorized as a chronic severe highly heritable brain disease. Symptoms include positive, negative, and cognitive symptoms. Despite numerous theories concerning the etiopathogenesis of SZ, the symptoms, although characteristic in their phenomenology, manifest themselves in a rather heterogeneous manner, which makes them subject to clinical assessment and, at the same time, prone to errors resulting from diverse interpretations of the context of the patient′s statements. Therefore, current research is focusing on identifying more subtle and stable features of SZ, such as the phenotype, endophenotype, and assessable abnormalities devoid of human clinical observation. The various biomarker developments focus on the role of transmitters and their corresponding receptors, in particular: glutamate, acetylcholine, dopamine, or serotonin. Also important in terms of etiopathogenesis remain growth factors such as brain‐derived neurotrophic factor (BDNF), nerve growth factor receptor (NGFR), or vascular endothelial growth factor (VEGF). More recently, research has emphasized the role of inflammatory processes and secreted pro‐ as well as anti‐inflammatory cytokines, included in the class of interleukins, chemokines, and tumor necrosis factors, as well as on inflammatory markers—C‐reactive protein (CRP) or glutathione (GSH). Increasingly, changes at the genetic level have been implicated as the cause of diseases, and it is now believed that noncoding RNAs (micro‐RNA [miRNA], long noncoding RNA [lnc‐RNA], and circular RNA [circRNA]) are involved in the development of SZ. Among the genes that may prove to be potential biomarkers in SZ belong SEDT1A, FOXP2, GRIN2A, GRIA3, NRN1, BDNF, CACNA1C, and ZNF8A4. The peptide group molecules, Phospholipase A2, Klotho protein, and soluble urokinase plasminogen activator receptor (suPAR), also remain consistently important. From the perspective of SZ as a disease associated with neuronal damage, biomarkers correlating with brain injury, neuron‐specific enolase (NSE), and S100B protein should be considered.

13 October 2025 in Medicina
Verified
Journal Article
Open access
PDF file
ASAlicja Sierakowska
Alicja Sierakowska
ENEwa Niewiadomska
Ewa Niewiadomska
SŁSebastian Łabuda
Sebastian Łabuda
ABAnna Bieniasiewicz
Anna Bieniasiewicz
MRMateusz Roszak
Mateusz Roszak
BŁBeata Łabuz-Roszak
Beata Łabuz-Roszak
Background and Objectives: Neuron-specific enolase (NSE) is an isoenzyme of enolase, of which the γ isoform is expressed in nerve cells. The activity of NSE occurs during late neuronal differentiation, which determines the specificity of the enzyme for neurodevelopmental cells. The activity of NSE is also observed in processes associated with neuronal damage. The aim of this study was to present the state of the art related to the knowledge, advances, and possible developmental directions in terms of the use of NSE as a biomarker in the diagnosis of selected neurological and mental disorders (NDs, MDs), with particular emphasis on ischemic stroke (IS) and psychotic disorders (PSDs). Materials and Methods: A literature review was performed using the PubMed, Embase, and Scopus databases. Keywords such as “neuron-specific enolase”, “neuron-specific enolase in schizophrenia”, “neuron-specific enolase in ischemic stroke”, “neuron-specific enolase in psychiatric disorders”, and “neuron-specific enolase in neurological diseases” were used during the literature search. A total of 11,350 items were found. However, 188 papers were finally selected after applying the filters (“clinical trial”, “meta-analysis”, “randomized control trial”, and “systematic review”). Results: The literature was analyzed and 67 items relevant to the subject of this study were selected. This article points out the differences in NSE levels in different clinical groups, such as patients after an incident of hypoxic/ischemic encephalopathy (HIE), neuroinfection, or particular inflammatory processes in the nervous system region, as well as central nervous system (CNS) injury, selected MD, neurodegenerative disorders (NGDs), headaches, or epilepsy (EP). Conclusions: In the future, they may serve to support further work on the use of enolase as a potential biomarker of the described diseases.

1 December 2021 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
AZAnita Zdanek
Anita Zdanek
BŁBeata Łabuz-Roszak
Beata Łabuz-Roszak
PSPatryk Szlacheta
Patryk Szlacheta
KTKatarzyna Tomczyk
Katarzyna Tomczyk
KWKarolina Wąsek
Karolina Wąsek
IKIlona Korzonek-Szlacheta
Ilona Korzonek-Szlacheta
The aim: To examine the level of knowledge and attitudes of high school students in the field of eating disorders. Materials and methods: The study group consisted of students of a randomly selected village school (Jendrzejow) and the municipal school (Siemianowice Slaskie). The study was conducted using an original survey consisting of 10 questions regarding the knowledge and attitudes of respondents towards eating disorders. Results: A total of 313 students (242 female and 71 male) participated in the study. 44.7% of respondents from the village school and 56.6% of respondents from the municipal school were dissatisfied with their appearance; 21.6% and 27.9%, respectively, were currently using the diet. 68% of students from Jędrzejow and 53.3% of students from Siemianowice Slaskie made an attempt to reduce body weight at least once in their lives. 55.1% of the village school respondents and 47.4% of the municipal school respondents noticed the influence of the media on the desire to achieve a slim figure. Girls showed better knowledge about eating disorders than boys (p = 0.008). Over 70% of students of both surveyed high schools believed that people with eating disorders are unable to cope with the disease on their own. Only 6.7% of students of the municipal school and 12.92% of students of the village school gave themselves a very good grade. Conclusions: There is a need to educate young people more broadly about eating disorders and the risk factors for their occurrence.

1 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BŁBeata Łabuz-Roszak
Beata Łabuz-Roszak
ASAnna Starostka-Tatar
Anna Starostka-Tatar
MGMaja Górniak
Maja Górniak
KWKacper Wojcicki
Kacper Wojcicki
KNKrzysztof Nalewajko
Krzysztof Nalewajko
MGMarek Gierlotka
Marek Gierlotka
Background: Depression is a known stroke risk factor, but its influence on stroke course depending on gender and age is not clearly defined. The purpose of this study was to determine the impact of previously diagnosed depression on early and one-year mortality in patients with acute ischemic stroke (IS) in relation to gender, age, and concomitant diseases. Methods: This study was based on the registry created from the public health insurer in Poland (2009–2020). Two groups were distinguished: IS-D—patients with IS and a diagnosis of depression within preceding 5 years (n = 520); IS-nD—patients with IS who had never been diagnosed with depression (n = 11,505). Results: In-hospital, 30-day, and 1-year mortality did not differ between groups (3.8% vs. 5.1%, 13.1% vs. 12.9%, and 27.1% vs. 26.8%, respectively). However, when statistical analysis was performed stratified by gender and age, we found a significantly higher 30-day and 1-year mortality in men under the age of 65 with previously diagnosed depression in comparison to those without depression (13.6% vs. 3.8%, p < 0.001; and 20.3% vs. 10.8, p < 0.021, respectively). Conclusions: The incidence of post-stroke depression was higher in IS-D group, regardless of gender and age. Early and one-year mortality was higher in younger men with IS and previously diagnosed depression.